Skip to main content

Site notifications

COZAAR losartan potassium 50 mg tablet blister pack, Organon Pharma Pty Ltd, CON-783

Product name
COZAAR losartan potassium 50 mg tablet blister pack
Sponsor name
Organon Pharma Pty Ltd
Consent start
Consent no.
CON-783
Duration
The consent is effective for all batches imported and supplied from 10 May 2021 until 31 March 2022.
Standard
Paragraph 8(1)(i), subsection 9(2), paragraph 9(3)(a) and subsection 9(5) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The products do not conform to the requirements of paragraph 8(1)(i), subsection 9(2), paragraph 9(3)(a) and subsection 9(5) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines in that Trade name is disrupted by additional text such as the active ingredient strength.The name of the medicine and active ingredient do not appear as a cohesive unit on separate lines and are not immediately below the name of the medicine.The text height of the active ingredient and strength is not 3 mm or greater.Name and contact details in respect of a sponsor or distributor has not been updated.
Conditions imposed
          ​The cartons exempted from TGO 91 are identical to those approved by the Therapeutic  Goods  Administration.       This exemption only applies to the products specified in the request.       
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines

Help us improve the Therapeutic Goods Administration site